Karex Bhd (XKLS:5247) EBIT: RM-11.9 Mil (TTM As of Mar. 2026)

What is Karex Bhd EBIT?

Karex Bhd XKLS:5247 +1.03% 41 EBIT is RM-11.9 Mil as of Mar. 2026. GuruFocus rates XKLS:5247 with a GF Score™ of 41/100 and a GF Value™ of RM0.76 (Possible Value Trap). The stock has 6 warning signs investors should review.

Karex Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM-5.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-11.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Karex Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was -2.75%. Karex Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -3.83%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Karex Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -1.69%.

Karex Bhd (XKLS:5247) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Karex Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-20.244 * ( 1 - 11.52% )	/	( (654.81	+	646.478)	/ 2 )
=	-17.9118912	/	650.644
=	-2.75 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	791.91	-	91.501	-	( 45.599	-	max(0, 255.984	-	343.232	+	45.599	))
=	654.81

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	774.357	-	88.095	-	( 39.784	-	max(0, 241.082	-	322.144	+	39.784	))
=	646.478

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Karex Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-19.948	/	( ( (333.354 + max(192.496, 0))	+	(335.999 + max(180.971, 0)) )	/	2 )
=	-19.948	/	( ( 525.85	+	516.97 )	/	2 )
=	-19.948	/	521.41
=	-3.83 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(124.827	+	171.219	+	1.587)	-	(91.501	+	0	+	13.636)
=	192.496

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(101.421	+	177.333	+	3.606)	-	(88.095	+	0	+	13.294)
=	180.971

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Karex Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	-11.944	/	704.983
	=	-1.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Karex Bhd EBIT Related Terms

Karex Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Karex Bhd's EBIT can be seen below:

Karex Bhd EBIT Chart

Karex Bhd Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

EBIT

Get a 7-Day Free Trial

2.13

-2.55

22.56

39.83

8.37

Karex Bhd Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															8.51	-10.83	6.98	-3.11	-4.99

XKLS:5247 vs PG, CL, KVUE: EBIT Comparison

For the Household & Personal Products subindustry, Karex Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karex Bhd EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Karex Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Karex Bhd's EV-to-EBIT falls into.

Save Embed

41GF Score

Karex Bhd XKLS:5247

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Karex Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-11.9 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of RM-11.9 Mil mean?

Karex Bhd (XKLS:5247) has a EBIT of RM-11.9 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Karex Bhd.

Is Karex Bhd's EBIT too high?

Karex Bhd's current EBIT is RM-11.9 Mil. Overall, Karex Bhd has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Karex Bhd's EBIT compare to PG and CL?

Karex Bhd's EBIT of RM-11.9 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Consumer Packaged Goods company?

A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Karex Bhd. Karex Bhd's current EBIT is RM-11.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Karex Bhd stock overvalued right now?

Based on GuruFocus' analysis, Karex Bhd (XKLS:5247) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.76, compared to a current price of RM0.49 — trading 35.5% below its estimated fair value. The current EBIT is RM-11.9 Mil. Karex Bhd's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Karex Bhd (XKLS:5247), the current EBIT is RM-11.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Karex Bhd (XKLS:5247) Overvalued in 2026?

Based on GuruFocus' analysis, Karex Bhd stock appears to be undervalued. The current stock price of RM0.49 is trading 35.5% below its estimated GF Value™ of RM0.76. GuruFocus considers Karex Bhd to be Possible Value Trap.

Key valuation signals for XKLS:5247:

EBIT: RM-11.9 Mil
GF Value™: RM0.76 vs. price of RM0.49 (35.5% below fair value)
GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the XKLS:5247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Karex Bhd Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies XKLS:2755 XKLS:5066 XKLS:0333 XKLS:5081 XKLS:0049 XKLS:7149 PG XPAR:OR LSE:ULVR CL BOM:500696 LSE:RKT KVUE KMB EL XTER:HEN3 CHD OSTO:ESSITY B XTER:BEI TSE:4452

Address Lot 594, Persiaran Raja Lumu, Pandamaran Industrial Estate, Port Klang, SGR, MYS, 42000

Website https://www.karex.com.my

Karex Bhd is a Malaysian investment holding company. Along with its subsidiaries, its main business activities comprise investment holding, manufacture, and sale of sexual wellness, medical, and other health-related products. These activities are located in Malaysia, Thailand, the United States of America, and the United Kingdom. It is principally engaged in manufacturing and selling condoms, personal lubricants, latex probe covers, oral dams, and others. The operating segments of the company are Sexual wellness, which generates maximum profits, Medical, and Others. Geographically, it derives key revenue from the Americas and the rest from Asia, Europe, and Africa.

41GF Score

Get the complete analysis for XKLS:5247

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.49

Price

RM0.76

GF Value

View XKLS:5247 Analysis

See EBIT data for all stocks →